Amylyx Pharmaceuticals Funding: $172M Raised, Series C
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts. It has raised $172M in total funding. Latest round: Series C.
Amylyx Pharmaceuticals funding overview
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts. Amylyx Pharmaceuticals has raised $172M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2021. The round record for Amylyx Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace and 7 others. 13 distinct backers are named across the disclosed rounds.
Amylyx Pharmaceuticals at a glance
Total raised
$172M
Latest round
Series C
Latest round date
July 2021
Headquarters
Cambridge, Massachusetts
Notable investors
Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace, Morningside Ventures, Perceptive Advisors
Frequently asked about Amylyx Pharmaceuticals funding
How much has Amylyx Pharmaceuticals raised?
Amylyx Pharmaceuticals has raised $172M in total disclosed funding across the rounds on record.
Who has invested in Amylyx Pharmaceuticals?
Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace are named among the investors backing Amylyx Pharmaceuticals.
What was the latest Amylyx Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in July 2021.
Where is Amylyx Pharmaceuticals based?
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts.
When did Amylyx Pharmaceuticals last raise?
The last disclosed Amylyx Pharmaceuticals round closed in July 2021 at Series C.
Every Amylyx Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
